PD-L2 has been suggested to play a role in inducing immune tolerance under physiological and pathological conditions (Latchman et al., 2001; Rozali et al., 2012), while also promoting CD8+ T cell-mediated anti-tumor immunity (Liu et al., 2003). This evidence concerns the gene CD8A and neoplasm.